GMO.
Boston asset management firm
- Reports this week
- 0
- Active events
- 0
- Connections
- 43
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Institutional investors are buying shares of the NYSEARCA:QLTY ETF.Some support1 report
-
Grantham predicts SpaceX shares will plunge one day.Well supported5 reports
-
Jonathan Gruber criticized public misunderstanding of GMOs, coinciding with the US adopting a permissive approach to GMO regulation.Some support1 report1 development inside
-
GMO dominates U.S. corn and soybean production, with studies tainted by financial conflicts of interest.Some support1 report
-
Philip Pilkington, a former employee of the GMO fund, is currently analyzing the issues surrounding Iran's oil market.Some support1 report
-
GMO, UBS, and Capital Economics are providing market analysis and warning about potential market bubbles.Some support2 reports
-
GMO monitors gender inclusion in Rwanda while Parliament approves the national budget.Some support1 report
-
Hedge funds, including Sanctuary Advisors and Aspen Investment Management, increased their stakes in an ETF associated with GMO on June 29, 2026.Some support3 reports
-
GMO warns that the AI boom is creating the biggest bubble in US history, leading to economic downturns.Well supported7 reports
-
Fifth Third Bancorp acquired a new position in the GMO U.S. Value ETF, which was recently issued by GMO.Some support7 reports
-
Lazard Asset Management LLC lifted its stake in the GMO ETF.Some support2 reports
-
Institutional figures, including GMO co-founder Jeremy Grantham, warn of a recession and AI bubble, signaling caution in high-risk assets.Well supported4 reports
-
The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.Some support1 report
-
GMO, led by its Chairman of the Board, announced on July 21, 2025, that it pays dividends denominated in Euro.Some support1 report
-
GMO analysis suggests market strategy hinges on valuations reverting to historic mean amid concentration risk and high P/E ratios.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around GMO this week
News at the entities that move GMO most-
FDA StructuralFDA accepted Axion BioSystems' Letter of Intent (LOI) for a neural assay on November 10, 2026.Moves GMO
-
Nigeria OperationalThe CBN backed Nigeria's National Mass Metering Programme, and the Buhari administration introduced the Meter Asset Provider framework.Moves GMO
-
SEC StructuralA company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.Moves GMO
-
Fifth Third Bancorp TransactionalFifth Third Bancorp acquired a new position in AB California Intermediate Municipal ETF shares in Q1 2026.Moves GMO
-
OpenAI Mentioned togetherResorts World Las Vegas utilized the OASYS platform to create an AI agent, integrating capabilities from acquired companies and third-party models like OpenAI.Moves GMO
-
Microsoft TransactionalGitHub has been placed under Microsoft's CoreAI unit.Moves GMO
Connections
The 23 strongest of 43, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Jeremy Grantham Structural
Jeremy Grantham is the co-founder and key figure of the investment firm GMO.
-
Philip Pilkington Structural
Pilkington was employed by the GMO fund.
-
FDA Structural
The FDA formally reviews genetic engineering products developed by GMO as part of the market approval process.
-
Microsoft Transactional
GMO executed a significant investment by purchasing over 900,000 shares of Microsoft.
-
Nigeria Operational
GMO products are being commercialized and their market push is challenging Nigeria's national seed sovereignty.
-
Lazard Asset Management LLC Transactional
Lazard Asset Management LLC divested its stake in GMO ETF.
-
Fifth Third Bancorp Transactional
Fifth Third Bancorp acquired a new position in GMOV, representing a financial investment transaction.
-
Ministry of Finance and Economic Planning Operational
GMO provides functional feedback to the Ministry of Finance and Economic Planning.
Show all 23 connections
-
SEC Structural
GMO ETF is subject to regulatory oversight and filing requirements by the SEC.
-
Rwanda Mentioned together
GMO monitors gender inclusion issues within the country of Rwanda.
-
Xavier Gabaix Mentioned together
GMO and Xavier Gabaix are noted for performing similar market analysis.
-
Rural Agricultural Development Authority Operational
The Rural Agricultural Development Authority CEO supports the use of GMO products for agricultural recovery.
-
Capital Economics Mentioned together
Both GMO and Capital Economics publicly warned of potential market bubbles.
-
OpenAI Mentioned together
GMO cited OpenAI's share issuance as a warning sign in its financial analysis.
-
Warren Buffett Mentioned together
Both GMO and Warren Buffett are discussed in the context of investment philosophy.
-
Anthropic Mentioned together
GMO has publicly commented on the potential market risks within the AI sector where Anthropic operates.
-
UBS Mentioned together
Both GMO and UBS are noted for providing market analysis.
-
SpaceX Mentioned together
GMO provides expert analysis and tracks market trends related to SpaceX's business lifecycle and IPO.
-
Bitcoin Mentioned together
The evidence establishes that GMO was co-founded by Jeremy Grantham, a top neighbor of GMO, but provides no direct evidence of a relationship between GMO and Bitcoin.
-
Jonathan Gruber Mentioned together
Jonathan Gruber criticized the public misunderstanding regarding GMO.
-
Congress Shared context
GMO operates within the legislative and funding context of Congress, seeking appropriations.
-
Fortune Mentioned together
Both entities were observed publishing market warnings.
-
American Mentioned together
No evidence found linking GMO and American in the provided timeline.
History
Events by the month they beganOctober 2026
1 eventAugust 2026
2 eventsJuly 2026
7 events- Institutional investors are buying shares of the NYSEARCA:QLTY ETF.
- Grantham predicts SpaceX shares will plunge one day.
- Jonathan Gruber criticized public misunderstanding of GMOs, coinciding with the US adopting a permissive approach to GMO regulation.
- GMO dominates U.S. corn and soybean production, with studies tainted by financial conflicts of interest.
- Philip Pilkington, a former employee of the GMO fund, is currently analyzing the issues surrounding Iran's oil market.
- GMO, UBS, and Capital Economics are providing market analysis and warning about potential market bubbles.
- GMO monitors gender inclusion in Rwanda while Parliament approves the national budget.
Show 1 earlier month
June 2026
8 events- Hedge funds, including Sanctuary Advisors and Aspen Investment Management, increased their stakes in an ETF associated with GMO on June 29, 2026.
- GMO warns that the AI boom is creating the biggest bubble in US history, leading to economic downturns.
- Fifth Third Bancorp acquired a new position in the GMO U.S. Value ETF, which was recently issued by GMO.
- Lazard Asset Management LLC lifted its stake in the GMO ETF.
- Institutional figures, including GMO co-founder Jeremy Grantham, warn of a recession and AI bubble, signaling caution in high-risk assets.
- The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.
- GMO, led by its Chairman of the Board, announced on July 21, 2025, that it pays dividends denominated in Euro.
- GMO analysis suggests market strategy hinges on valuations reverting to historic mean amid concentration risk and high P/E ratios.